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Abstract
Background: While risk factors of osteoporosis in Western populations have been extensively
documented, such a profile has not been well studied in Caucasians of non-European origin. This
study was designed to estimate the modifiable distribution and determinants of bone mineral
density (BMD) among Iranian women in Australia.
Methods:  Ninety women aged 35 years and older completed a questionnaire on socio-
demographic and lifestyle factors. BMD was measured at the lumbar spine (LS) and femoral neck
(FN) using DXA (GE Lunar, WI, USA), and was expressed in g/cm2 as well as T-score.
Results: In multiple regression analysis, advancing age, lower body mass index (BMI), and smoking
were independently associated with LS and FN BMD, with the 3 factors collectively accounting for
30% and 38% variance of LS and FN BMD, respectively. LS and FN BMD in smokers was 8% lower
than that in non-smokers. Further analysis of interaction between BMI and smoking revealed that
the effect of smoking was only observed in the obese group (p = 0.029 for LSBMD and p = 0.007
for FNBMD), but not in the overweight and normal groups. Using T-scores from two bone sites
the prevalence of osteoporosis (T-scores ≤  -2.5) was 3.8% and 26.3% in pre-and post-menopausal
women, respectively. Among current smokers, the prevalence was higher (31.3%) than that among
ex-smokers (28.6%) and non-smokers (7.5%).
Conclusion: These data, for the first time, indicate that apart from advancing age and lower body
mass index, cigarette smoking is an important modifiable determinant of bone mineral density in
these Caucasians of non-European origin.
Background
Osteoporosis is a common disorder in the elderly popula-
tion, and represents one of the most significant public
health problems in the world, predisposing to fractures
with minimal or no antecedent trauma. These fractures
are, in turn, associated with increased morbidity [1],
reduced quality of life [2], mortality [3], and high health
care costs [4].
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Bone mineral density (BMD) measurement is considered
an effective predictor of fracture risk, such that each stand-
ard deviation lower in BMD is associated with at least a 2-
fold increase in age adjusted fracture risk. [5-7]. Therefore,
a useful approach in assessing the importance of aetiolog-
ical factors for osteoporosis is an investigation of the dis-
tribution and determinants of BMD. Although
determinants of bone mineral density in Western popula-
tions have been extensively studied, such a profile has not
been well documented in Caucasians of non-European
origin.
Body weight or body mass index (BMI) is known to be
positively associated with BMD[8,9]. Lifestyle factors such
as low calcium intake, lack of physical activity, and smok-
ing adversely affect bone mineral density and increase the
risk of osteoporosis and its related fractures[10]. These
factors also play an important role in the determination of
peak bone mass and subsequent bone loss during the
post-menopausal period. Among the modifiable risk fac-
tors of osteoporosis, cigarette smoking is considered one
of the deleterious factors because cigarette smokers also
have increased risk of fracture[11,12]. Nevertheless, the
interactive effect of smoking on BMD has not been well
studied. A recent study in a Caucasian population sug-
gested that the effect of smoking was modified by body
mass index, such that non-obese smokers had lower BMD
than obese-smokers[13]. Iranian women on the average
have a relatively high BMI[14,15], and it is not known
whether such an interaction effect between smoking and
BMI is present in this population.
The present study was designed to examine the modifiable
distribution and determinants of bone mineral density
among Iranian Australian women.
Methods
Subjects and setting
This study was designed as a cross-sectional investigation.
All women were recruited via a media campaign using
newsletters, noticeboards in community halls as well as
word of mouth at community centres as part of a larger
study to examine osteoporosis prevention in Iranian
women. Inclusion criteria for the study were Iranian
women and aged 35 years or older. The exclusion criteria
were: current or past occurrence of any medical conditions
known to affect bone metabolism such as Paget's disease
and stroke; current pregnancy; and/or a history of breast-
feeding within the last year. Also excluded were women
who had been taking any medication affecting bone such
as hormones, calcium, and glucocorticoids. In total, 96
women participated in the current study. Six women, who
did not meet study's criteria on the basis of diseases or his-
tory of taking medications affecting bone, were excluded
from the analysis. This study was approved by the Univer-
sity of New South Wales's Human Research Ethics Com-
mittee and written informed consent was obtained from
each participant.
Data collection and measurements
Socio-demographic characteristics and lifestyle risk factors
Each woman completed a modified structured question-
naire [16] on socio-demographic and lifestyle risk factors.
Income was included to be assessed, however, most par-
ticipants refused to obtain information about their
income level. Reproductive factors such as menopausal
status and years since menopause were also provided for
each participant. Menopause was defined as previous nat-
ural or surgical cessation of menstruation for more than
12 months. Calcium intake was calculated as the sum of
current intake of main dairy products (milk, yogurt, and
cheese) and was then converted to milligrams of calcium
per day. Calcium contents for dairy products were pro-
vided from the product information in Australia [17].
Exercise was dichotomized as "yes" for current regular
exercising, or "no" for not exercising. Amongst those who
exercised, total amount of time spent per week was
recorded. Current alcohol use was recorded as "yes" for
drinking alcohol (beer, wine and liquor), or "no" for no
intake of alcohol. Smoking habits were assessed based on
previous and current cigarette smoking. Smoking status
was dichotomized as "yes" for smoking, or "no" for never
smoking. In addition, amongst those who smoked, dose
and duration of smoking was recorded.
Anthropometric data
Weight (kg) and height (cm) were measured with light
indoor clothing without shoes at the time of bone densit-
ometry measurements. Weight was recorded to the nearest
tenth of a kg using an electronic scale and standing height
was measured to the nearest centimeter with a stadiome-
ter. Body mass index (BMI) was calculated as body weight
in kilograms divided by height in meters squared. Accord-
ing to the World Health Organization (WHO) recom-
mended classification system, overweight and obese
individuals were classified as having a BMI between 25
and 29, and equal to or greater than 30 kg/m2,
respectively[18].
Bone density measurement
BMD was measured at the lumbar spine (LS) (L2-L4, ante-
rior-posterior position) and femoral neck (FN) using
dual-energy X-ray absorptiometry (DXA) with a Lunar
Prodigy densitometer (GE Lunar, WI, U.S.A.). Areal BMD
was expressed in g/cm2 and in standard deviations from
the young normal mean (T-score), based on the Austral-
ian Reference Population. The sample of women was
grouped into 3 groups based on the WHO recommended
criteria: osteoporosis if T-score ≤  -2.5; osteopenia if -2.5 <
T-score ≤ -1.0; and normal if T-score >-1.0 [19].BMC Musculoskeletal Disorders 2005, 6:34 http://www.biomedcentral.com/1471-2474/6/34
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Data analysis
To determine the magnitude of association between the
potential risk factors (e.g., menopausal status, height,
weight, dairy calcium intake, smoking, exercise, and alco-
hol use) and osteoporosis risk. Bone mineral density was
considered the primary outcome, and was treated as a
continuous variable. Individual risk factors were first con-
sidered in a simple linear regression analysis to estimate
the strength of association between individual risk factor
and BMD. In the subsequent analysis, all risk factors were
simultaneously considered in a multiple linear regression
analysis using the backward elimination algorithms, to
screen for independent significant factors. Residual analy-
sis performed to ensure that the usual assumptions of the
regression model (i.e. normality, homogeneity and inde-
pendence) were met. The entry of significance level (p
value) was set to 0.10 to arrive at the most robust model.
In further analysis, differences between the pre-menopau-
sal and post-menopausal groups were tested by unpaired
t-test for the normally distributed variables, or the Mann-
Whitney U test for non-normally distributed variables,
and Chi-square test for categorized data. The analysis was
performed with the SAS statistical analysis system[20] and
SPSS for Windows statistical software [21].
Results
Characteristics of study subjects
The study population consisted of 90 women aged 48.5 ±
8.3 yr (mean age ± SD; range: 35 to 77 yr). Approximately
42 % of the women had education within high school.
The majority of the women were married (78%) and per-
forming home duties or not employed (56%). Their aver-
age duration of residence in Australia was about 10 years,
with 75% of subjects having resided in Australia for at
least 5 years. The mean age (SD) at immigration was
about 39 ± 9.4 yr (range: 18 to 65 yr). The median (SD)
dairy calcium intake in the women was 407 ± 283 mg/day.
The Twenty-three women (26%) exercised regularly.
Approximately 26% of women smoked cigarettes during
their lifetime. Although cigarette smoking was common
in these subjects, alcohol use was not frequent with about
11% of the women reporting drinking any kind of alco-
hol. Using the BMI criteria, 2.2% of subjects were under-
weight; 25.6% of women were in the healthy weight
range; 35.6% were over-weight; and 36.7% were obese.
Forty two percent (n = 38) of women were post-menopau-
sal, with the duration of post-menopause being between
1 and 32 years. Post-menopausal women had significantly
higher age and parity and lower height, lumbar spine and
femoral neck BMD, but no significant differences were
found between the pre-and post-menopausal women in
weight, BMI, dairy calcium intake, exercise, smoking sta-
tus, duration of smoking, and alcohol use (Table 1).
Table 1: Clinico-demographic characteristic of study subjects
Pre-menopause Post-menopause p value
N5 2 3 8
Age (years)* 43.6 ± 4.7 55.18 ± 7.4 <0.001a
Height (cm)* 157.7 ± 5.5 155 ± 5.7 0.027a
Weight (kg)* 70.8 ± 16.4 68.9 ± 10.3 0.530a
BMI (kg/m2)* 28.5 ± 6.9 28.7 ± 4.3 0.869a
LSBMD (g/cm2)* 1.19 ± 0.15 1.04 ± 0.16 <0.001a
FNBMD (g/cm2)* 0.97 ± 0.12 0.87 ± 0.11 <0.001a
Dairy calcium intake (mg/day)* 410 ± 262 498 ± 306 0.147a
Age at menopause* - 47.9 ± 4.02 -
Parity† 2 (2, 3) 3 (2, 4) 0.004b
Regular exercise§ 12 (23.1) 11(28.9) 0.528c
Smoking status
Current smokers 15.4 (8) 21.1 (8) 0.487c
Ex-smokers 21.2 (11) 23.7 (9) 0.775c
Duration of smoking (years)§ 0.155c
≤  5 4 (33.3) 1 (9.1)
> 5 8 (66.7) 10 (90.9)
Alcohol use§ 7 (13.5) 3 (7.9) 0.407c
*Mean ± SD; †median (interquartile range); § n (%).
aunpaired t-test, bMann-Whitney U test, cChi-square test.
BMI, body mass index; LSBMD, lumbar spine bone mineral density; FNBMD, femoral neck bone mineral density.BMC Musculoskeletal Disorders 2005, 6:34 http://www.biomedcentral.com/1471-2474/6/34
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Determinants of BMD
In simple linear regression analysis, age, height, weight,
BMI, menopausal status, smoking habits, duration of
smoking, and cigarette dose were each significantly asso-
ciated with LS and FN BMD (Table 2). However, in the
multiple linear regression, advancing age, lower BMI and
smoking were independent predictors of LS and FN BMD
(Table 3). After adjusting for age and BMI, smokers had
0.087 g/cm2 (8 %) and 0.075 g/cm2 (8 %) lower in LS and
FN BMD, respectively, than non-smokers. The 3 factors
collectively accounted for 30% and 38% of the variation
in LS and FN BMD, respectively.
As expected, advancing age was negatively associated with
BMD in the both sites (LS: r = 0.45, p = 0.0001; FN: r =
0.50, p = 0.0001). Nevertheless, there was a significant
positive correlation between BMI and LS and FN BMD
(LS: r = 0.22, p = 0.033; FN: r = 0.26, p = 0.012). Current
smokers had significantly lower lumbar spine and femo-
ral neck BMD than non-smokers. However, there was no
significant difference between ex-smokers and non-smok-
ers in both BMD sites (Fig. 1). Among smokers, there was
no significant linear correlation between cigarette dose
and BMD (p = 0.14 for LSBMD and p = 0.64 for FNBMD)
and duration of smoking and BMD (p = 0.76 for LSBMD
and p = 0.86 for FNBMD).
Further analysis of interaction between BMI and smoking
revealed that the effect of smoking was only observed in
the obese group (p = 0.029 for LSBMD and p = 0.007 for
FNBMD), but not in the overweight and normal groups
(Fig. 2). This interaction effect was not affected by the
dose of cigarette or duration of smoking. Moreover, there
was a non-statistically significant interaction between age
and smoking, as both smokers and non-smokers
appeared to have a similar age-BMD association (Fig. 3).
Prevalence of low bone density
Twenty-five women (27.8%) were osteopenic (T-score -1
to -2.49) at the lumbar spine and 32 (35.6%) at the fem-
oral neck. Using the WHO T-score-based definition of
osteoporosis, the proportion of women with osteoporosis
was 12.2% (n = 11) at the lumbar spine and 2.2% (n = 2)
at the femoral neck. When the two measures were consid-
ered simultaneously, the prevalence of osteoporosis was
13.3%. In post-menopausal women, the prevalence of
osteoporosis (T-score ≤  -2.5) was 23.7% (n = 9) at the
Table 2: Univariate association between individual risk factors and bone mineral density
Factor LSBMD (g/cm2)F N B M D  ( g / c m 2)
β  ± SE a R2b β  ± SEa R2b
Age (per 1 year) -0.009 ± 0.002* 0.20 -0.008 ± 0.001* 0.25
Height (per -5 cm) 0.04 ± 0.012* 0.07 0.030 ± 0.010* 0.07
Weight (per -5 kg) 0.02 ± 0.005* 0.10 0.015 ± 0.005* 0.14
BMI (per -5 kg/m2) 0.035 ± 0.015* 0.05 0.030 ± 0.010* 0.07
Post-menopause -0.153 ± 0.033* 0.19 -0.103 ± 0.026* 0.15
Smoking (current and ex-smokers) -0.100 ± 0.040* 0.06 -0.086 ± 0.030* 0.08
Duration of smoking (per 5 years) -0.037 ± 0.015* 0.06 -0.031 ± 0.011* 0.07
Cigarette dose (per 10 cig/day) -0.054 ± 0.019* 0.08 -0.038 ± 0.014* 0.07
Dairy calcium intake (per 300 mg/day) 0.020 ± 0.03 0.001 0.020 ± 0.03 0.02
Regular exercise (yes) 0.017 ± 0.042 0.002 0.044 ± 0.031 0.02
Alcohol use (yes) 0.004 ± 0.058 0.001 -0.021 ± 0.044 0.003
BMI, body mass index; LSBMD, lumbar spine bone mineral density; FNBMD, femoral neck bone mineral density.
* P < 0.05 (statistically significant)
a Values are regression coefficients ± SE describing the change in bone mineral density (g/cm2) associated with the unit change in the risk factor
b Coefficient of determination: the proportion of variation in bone mineral density explained by the variation in a risk factor
Table 3: Association between age, body mass index, smoking, 
and bone mineral density:Results of multiple linear regression 
analysis
Determinant LSBMD (g/cm2)a FNBMD (g/cm2)a
Age (per 1 year) -0.008 ± 0.002** -0.007 ± 0.001**
BMI (-5 kg/m2) 0.006 ± 0.003* 0.005 ± 0.002**
Smoking (yes) -0.087 ± 0.035* -0.075 ± 0.025**
R2* 0.30 0.38
*0.01 <p < 0.05; **0.0001 <p < 0.01
a Values are regression coefficients ± SE describing the change in BMD 
(g/cm2) associated with one year advancing age, 5 kg/ m2 decrease in 
BMI and smoking status.
BMI, body mass index; LSBMD, lumbar spine bone mineral density; 
FNBMD, femoral neck bone mineral density.
* R2, coefficient of determination: a measure of the proportion of 
variation in BMD explained by the variation in the risk factors. The 
variables included in the initial regression analysis were: age, 
menopause status, BMI, smoking status, duration of smoking, cigarette 
dose, calcium intake, exercise, and alcohol useBMC Musculoskeletal Disorders 2005, 6:34 http://www.biomedcentral.com/1471-2474/6/34
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Mean and standard error of lumbar spine (upper panel) and femoral neck (lower panel) bone mineral density (g/cm2) by smok- ing status Figure 1
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Mean and standard error of lumbar spine (upper panel) and femoral neck (lower panel) bone mineral density (g/cm2) by body  mass index and smoking status Figure 2
Mean and standard error of lumbar spine (upper panel) and femoral neck (lower panel) bone mineral density (g/cm2) by body 
mass index and smoking status.
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Interaction between age and smoking status on lumbar spine (upper panel) and femoral neck (lower panel) bone mineral den- sity (g/cm2) Figure 3
Interaction between age and smoking status on lumbar spine (upper panel) and femoral neck (lower panel) bone mineral den-
sity (g/cm2).
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lumbar spine and 5.3% (n = 2) at the femoral neck.
Among smokers, the prevalence was 30.4% (7/23) which
was significantly higher (p < 0.01) than that among non-
smokers (7.5%, 5/67).
Discussion
Osteoporosis is recognized as a public health problem in
the world, but its epidemiology in non-Western popula-
tions remains poorly understood. This study represents an
original contribution to the study of osteoporosis in Ira-
nian women in Australia. Apart from advancing age and
body mass index, it was found that cigarette smoking was
an important modifiable determinant of bone mineral
density.
These results are consistent with previous studies which
indicated that advancing age was associated with lower
BMD. In this study, each year increase in age was esti-
mated to cross-sectionally "decrease" 0.8% in LS and FN
BMD. This estimate is relatively consistent with longitudi-
nal studies in Western Caucasian women which suggest
an annual decrease of 1%[22,23].
Consistent with previous studies[8,9], this study found
that lower BMI was associated with lower BMD. Moreo-
ver, the effect of smoking was significant in obese women.
The prevalence of current cigarette smoking in this popu-
lation (17.8%) was surprisingly higher than Iranian
women in Iran which was around 3.6%[24]. BMD in
smokers was 8% lower than in non-smokers, after adjust-
ing for age and BMI. This difference is clinically signifi-
cant, because each SD reduction in BMD is associated
with a 2-fold increase in age adjusted fracture risk.
BMD measurements in ex-smokers were intermediate
between current and non-smokers. It seems the effect of
smoking varies linearly with the intake of cigarette and
may suggest that smoking cessation have a positive effect
on both LS and FN BMD. This makes cigarette smoking
one of the important modifiable lifestyle risk factors of
osteoporosis in Iranian Australian women.
Although some studies found an association between cal-
cium intake and BMD, the present study found no such
association. The results also revealed a non-significant
relationship between exercise and BMD. One of the rea-
sons for these results may be that the questionnaire only
reflected the present situation, not permanent lifestyle. In
addition, frequency and type of exercise on bone density
could not be evaluated, because few of the subjects exer-
cised regularly.
Alcohol use was not significantly associated with bone
mineral density. Although cigarette smoking was com-
mon in this sample, alcohol use was not frequent and
only a few (11%) women reported drinking any kind of
alcohol, with the majority drinking only monthly or
rarely. With such a low prevalence of use, it is perhaps not
surprising that the study was unable to detect a significant
effect of alcohol use on BMD.
Using T-scores from two bone sites the prevalence of oste-
oporosis (T-scores ≤  -2.5) was 3.8% (n = 2) and 26.3% (n
= 10) in pre-and post-menopausal women, respectively.
The most notable observation in this study is that oste-
oporosis was more likely to be identified at the lumbar
spine than the femoral neck. This finding is consistent
with a previous study among Iranian women in Iran [25].
However, the prevalence of osteoporosis at the femoral
neck seemed to be relatively lower in the Iranian women
compared with most Asian and other Caucasian popula-
tions [26-29]. These results suggest that BMD measured at
the femoral neck requires further investigation in Iranian
women.
The present study's findings must be interpreted within
the context of a number of strengths and weaknesses. This
study is the first attempt to address an important public
health problem amongst Iranian women in an Australian
setting. Some aspects of acculturation should be taken
into account in the interpretation of these findings. Since
75% of women have settled in Australia for at least 5
years, change of lifestyle factors such as sun exposure and
diet cannot be ruled out, and the present results may not
be generalizable to Iranian women in Iran. The associa-
tion between risk factors and BMD as observed in this
study cannot be interpreted as a causal relationship
because the study was a cross-sectional investigation.
Because the women in this study were not sampled from
an age-stratified scheme, the average T-scores and preva-
lence of osteoporosis could have been affected by the
actual age group distribution, and this represents a poten-
tial limitation for generalizing the results to the general
population.
Conclusion
These data suggest that, apart from advancing age and
lower BMI, cigarette smoking is an important modifiable
determinant of bone mineral density in the Iranian Aus-
tralian women. These findings can potentially contribute
toward the development of more effective public health
strategies for the health promotion and osteoporosis pre-
vention in this population.
Further studies are required to investigate the effect of
changing environmental exposures which can influence
osteoporosis prevalence and fracture risk in this
population.BMC Musculoskeletal Disorders 2005, 6:34 http://www.biomedcentral.com/1471-2474/6/34
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